FAQ: ADAP Advocacy's Commercial on 340B Program and Hospital CEO Compensation

What is the main purpose of ADAP Advocacy’s new commercial?

The commercial calls for reforms to the 340B Drug Pricing Program and highlights excessive executive compensation for 340B-eligible hospital CEOs, questioning whether the program has become ’too big to fail’ and benefits providers more than patients.

Why is ADAP Advocacy concerned about hospital CEO compensation?

Hospital CEOs are being compensated 200-300% more than nurses providing direct patient care, largely financed by a program designed to help low-income patients access healthcare services, which ADAP Advocacy argues is intellectually dishonest and makes patients sick when they compare this pay to their medical debt.

What is the 340B Drug Pricing Program?

The 340B Drug Pricing Program is a program designed to help low-income patients access healthcare services, though the content does not provide specific details about how the program operates beyond its intended purpose.

Who is leading this advocacy campaign?

Brandon M. Macsata, CEO of ADAP Advocacy, is leading this campaign as part of the organization’s 340B Project, with the commercial being part of their ‘340B Too Big To Fail’ national advocacy campaign.

When is this advocacy campaign running?

The ‘340B Too Big To Fail’ national advocacy campaign will run through the end of the year, according to the content released on October 23, 2025.

What other issues does the campaign highlight besides CEO compensation?

The campaign also highlights hospitals’ declining charity care, rising healthcare executive compensation, and exploding patient medical debt, among other issues.

Where can I view the commercial mentioned in the content?

The commercial is available online at https://youtu.be/Q8zaGIZqDp4 and is also linked in the content as part of ADAP Advocacy’s 340B Project.

What resources does ADAP Advocacy provide to track these trends?

ADAP Advocacy provides an interactive map at 340bmap.org that has elevated trends related to hospital charity care, executive compensation, and patient medical debt.

Who should be concerned about this issue according to ADAP Advocacy?

Patients carrying medical debt should be concerned, as they learn about hospital CEO compensation levels and compare it to their debt burden, which ADAP Advocacy states ’literally makes them sick.’

How can I get more information about ADAP Advocacy or the 340B program?

You can email [email protected] to learn more about ADAP Advocacy, the 340B Drug Pricing Program, excessive hospital CEO pay, or the new 340B commercial.